Results
3042
Most Popular Stocks on the market
3042 companies
Ayr Wellness
Market Cap: CA$18.1m
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.
AYR.A
CA$0.15
7D
0%
1Y
-93.6%
Biosergen
Market Cap: SEK 123.5m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.53
7D
7.8%
1Y
-8.4%
atect
Market Cap: JP¥2.0b
Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses.
4241
JP¥445.00
7D
2.1%
1Y
-15.6%
Imunon
Market Cap: US$13.1m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$5.18
7D
4.0%
1Y
-61.8%
Vietnam Medicinal Materials
Market Cap: ₫343.5b
Produces and sells medicinal materials in Vietnam.
DVM
₫7,300.00
7D
0%
1Y
-17.2%
Gelteq
Market Cap: US$13.0m
Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.
GELS
US$1.40
7D
3.7%
1Y
n/a
OSR Holdings
Market Cap: US$13.0m
A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.
OSRH
US$0.58
7D
-23.3%
1Y
-94.7%
Liminal BioSciences
Market Cap: €11.8m
Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.
PJ2
€3.80
7D
0%
1Y
-0.7%
Chemomab Therapeutics
Market Cap: US$12.9m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.
CMMB
US$2.64
7D
-0.4%
1Y
-57.1%
Indo-Bangla Pharmaceuticals
Market Cap: ৳1.6b
Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.
IBP
৳13.50
7D
1.5%
1Y
27.4%
Mangalam Drugs & Organics
Market Cap: ₹1.1b
Together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
532637
₹72.07
7D
-5.0%
1Y
-43.3%
Aptorum Group
Market Cap: US$12.8m
Through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
APM
US$1.85
7D
3.9%
1Y
0%
Amwill Health Care
Market Cap: ₹1.1b
A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.
544353
₹56.38
7D
-4.4%
1Y
n/a
Verici Dx
Market Cap: UK£9.5m
Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.
VRCI
UK£0.0063
7D
-10.7%
1Y
-90.7%
Phio Pharmaceuticals
Market Cap: US$12.6m
A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.
PHIO
US$2.23
7D
7.7%
1Y
-36.3%
Polyrizon
Market Cap: US$12.6m
A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
PLRZ
US$1.08
7D
-3.6%
1Y
n/a
Hemostemix
Market Cap: CA$17.5m
A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.
HEM
CA$0.10
7D
-4.8%
1Y
0%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.017
7D
0%
1Y
30.8%
Oxford BioDynamics
Market Cap: UK£9.3m
Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.
OBD
UK£0.0047
7D
0%
1Y
-85.1%
NovaBay Pharmaceuticals
Market Cap: US$12.5m
Does not have significant operations.
NBY
US$2.19
7D
20.3%
1Y
208.5%
Valerio Therapeutics Société anonyme
Market Cap: €10.6m
A clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes.
ALVIO
€0.058
7D
-0.3%
1Y
-25.4%
Cilo Cybin Holdings
Market Cap: R213.8m
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide.
CCC
R3.01
7D
1.0%
1Y
-24.8%
PreveCeutical Medical
Market Cap: CA$17.1m
A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.
PREV
CA$0.035
7D
0%
1Y
133.3%
TherapeuticsMD
Market Cap: US$12.3m
Operates as a pharmaceutical royalty company in the United States.
TXMD
US$1.07
7D
-1.8%
1Y
-34.8%
Zenith Drugs
Market Cap: ₹1.1b
Manufactures and trades in branded, generic, and OTC medicines.
ZENITHDRUG
₹63.00
7D
-2.2%
1Y
-55.4%
Intensity Therapeutics
Market Cap: US$12.2m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.
INTS
US$0.24
7D
-2.3%
1Y
-93.7%
Rize Oncology
Market Cap: US$12.1m
A biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications.
RZON.F
US$0.16
7D
0%
1Y
n/a
Advent Pharma
Market Cap: ৳1.4b
A pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh.
ADVENT
৳15.50
7D
0.6%
1Y
-22.1%
Red White & Bloom Brands
Market Cap: CA$16.5m
Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.
RWB
CA$0.035
7D
0%
1Y
-46.2%
Oncodesign Precision Medicine Société anonyme
Market Cap: €10.1m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.55
7D
15.7%
1Y
-46.2%
Plant Advanced Technologies
Market Cap: €10.0m
A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.
ALPAT
€8.90
7D
-2.4%
1Y
-38.2%
Numinus Wellness
Market Cap: CA$16.1m
Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.
NUMI
CA$0.05
7D
0%
1Y
-33.3%
Mustang Bio
Market Cap: US$11.6m
A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.
MBIO
US$1.59
7D
-4.8%
1Y
-86.2%
BioRestorative Therapies
Market Cap: US$11.6m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.43
7D
-1.4%
1Y
-17.8%
Nanollose
Market Cap: AU$17.7m
A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.
NC6
AU$0.058
7D
-3.3%
1Y
205.3%
Sirona Biochem
Market Cap: CA$15.8m
A cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France.
SBM
CA$0.06
7D
0%
1Y
9.1%